PEOPLE ON THE MOVE

Second senior exit at AZ, and what's next for Takeda and Sanofi execs?

By Fiona BARRY

28-Jun-2015 - Last updated on 29-Jun-2015 at 11:18 GMT

Sanofi / Waypoint

AstraZeneca / Vectura

Related news

Follow us

Webinars

On-demand webinars

Diversity: Increasing trial inclusivity Webinar

Headlines

How Cure51’s AI breakthroughs are turning cancer into a manageable disease – an insider’s look
Revolutionary Alzheimer's drug donanemab approved – what does this mean for the future of care?
Ensuring pharma data integrity: COPA-DATA’s automation solution tackles ALCOA challenges
IQVIA’s One Home for Sites: Reducing tech overload in clinical research
Suzanne LeBlang - passionate about patient care and the Focused Ultrasound Foundation
Ask the experts: Should pharmacists take on more responsibility or is it a stretch too far?
AI, patient engagement, and interoperability: Innovations shaping clinical trials
Top 5 CDMOs driving advanced therapies to market amid rising demand and challenges
New drug safety era: Transparency’s portable test kits target every substance
ViiV Healthcare's new data shows promising maternal and pregnancy outcomes for Apretude use
Laura Child on passion, career challenges, and advice for young women in life sciences
FDA approves Rusan Pharma’s manufacturing facility in India, paving the way for expanded US presence
Phathom Pharmaceuticals receives FDA approval for Voquezna to treat non-erosive GERD
Avista and Hamilton Lane join forces to Propel growth and innovation at Cosette Pharmaceuticals